Europe Ophthalmology PACS Market

Europe Ophthalmology PACS Market Size (2023 to 2028)

The ophthalmology PACS market size in Europe is anticipated to be worth USD 68.69 million by 2028 from USD 45.99 million in 2023, growing at a CAGR of 8.35% from 2023 to 2028.

The growing population suffering from eye disorders in Europe majorly propels the European ophthalmology PACS market growth. An estimated 8.5 million individuals in Europe suffer from vision disorders, with common conditions such as refractive errors, age-related macular degeneration, cataract, glaucoma, amblyopia, and dry eyes. This has led to a growing awareness of the importance of pre-eye examinations to prevent or treat these conditions. To address these challenges, many health providers are utilizing PACS, a medical imaging technology that allows for secure storage and transmission of electronic images and relevant clinical reports. PACS is proving to be an effective tool for improving patient disease investigation, diagnosis, and treatment. Additionally, software and applications are being employed to integrate the data obtained from PACS for further analysis and utilization.

The growing aging population who are more prone to developing diabetic retinopathy and other eye-related conditions as they age in Europe further drives the European market growth. Advanced ophthalmic imaging with high resolution is proving to be a valuable tool for surgeons during the diagnosis and treatment of such conditions. The implementation of Picture Archiving and Communication Systems (PACS) technology enables the consolidation and management of data from various diagnostic devices, providing personalized treatment planning and reducing the search time required to achieve accurate diagnoses and effective treatments for patients.

The growing efforts by the manufacturers to bring advancements in ophthalmology PACS boosts the growth rate of the regional market. Manufacturers are prioritizing the expansion of Picture Archiving and Communication Systems (PACS) with greater storage capacity and accelerated data processing capabilities to prevent data loss and improve treatment efficiency. These incremental improvements to the PACS server facilitate cost savings by enabling comprehensive analysis of eye disorders. The growing R&D activities, favorable reimbursement procedures and regulatory approval of software and products for ophthalmology support the European market growth.

The high cost of system integration, data migration issues and technical complications primarily hamper the growth of the European ophthalmology PACS market. Ensuring data security within the PACS system poses a significant obstacle to the growth rate of the regional market. Limited availability of common imaging technologies, including optical coherence tomography, fundus autofluorescence imaging, and fluorescein angiography slows the regional market growth. Lack of awareness among the European population about the benefits of ophthalmology PACS and a shortage of skilled professionals in Europe further inhibit the European market growth.

This research report on the Europe ophthalmology PACS market has been segmented and sub-segmented into the following categories.

By Type:

• Integrated PACS
• Standalone PACS

By Delivery Model:

• On-premises
• Web/cloud-based

By End User:

• Hospitals
• Specialty Clinics & Ambulatory Surgery Centers
• Other End Users

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The European region held the second-largest share of the global ophthalmology PACS market in 2022 and is estimated to hold a substantial share of the worldwide market during the forecast period owing to the rising adoption of advanced technologies by eye care hospitals, increasing healthcare expenditure, the expansion of infrastructure facilities by eye care hospitals and the growing number of initiatives by the European governments to promote the adoption of ophthalmology PACS.

The UK had the major share of the European market in 2022 and is expected to register a healthy CAGR during the forecast period due to the presence of several market participants and an increasing number of conferences and programs aimed at raising awareness about eye health.

Germany accounted for a notable share of the European market in 2022 and is estimated to grow at a notable CAGR during the forecast period owing to the increasing investments by key market players and other healthcare organizations. As digitization continues to increase in response to growing patient populations, demand for PACS systems in the country is also increasing.

KEY MARKET PLAYERS:

Carl Zeiss Meditec AG, Topcon Corporation, Heidelberg Engineering GmbH, Merge Healthcare (IBM Watson Health) and Visbion Ltd are some of the notable companies in the European ophthalmology PACS market.